Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

Costa Clemens SA., Weckx L., Clemens R., Almeida Mendes AV., Ramos Souza A., Silveira MBV., da Guarda SNF., de Nobrega MM., de Moraes Pinto MI., Gonzalez IGS., Salvador N., Franco MM., de Avila Mendonça RN., Queiroz Oliveira IS., de Freitas Souza BS., Fraga M., Aley P., Bibi S., Cantrell L., Dejnirattisai W., Liu X., Mongkolsapaya J., Supasa P., Screaton GR., Lambe T., Voysey M., Pollard AJ., Bittaye M., Woods D., Davies S., Smith H., Ulaszewska M., Sanders H., Mabette R., Vernon S., Valliji Z., Mead G., Tejpal C., Park J., Beveridge A., Eldawi A., Felle S., Fraga M., Muniz Martins T., Martins Medrado CL., de Arruda Cordeiro Matos LJ.